The Pharma Partners (TPP) Announces June MedTech China Forum With WSGR
NEW YORK, NY–(Marketwired – April 30, 2015) – The Pharma Partners (TPP) is pleased to announce an event partnership with Wilson Sonsini Goodrich & Rosati (WSGR) to host the inaugural MedTech China Forum in Palo Alto on June 25, 2015. The event will adjoin WSGR’s 23rd Annual Medical Device Conference taking place on June 26, 2015.
As a boutique advisory firm specializing in cross-border deal flow and targeted at China’s healthcare industry, TPP will focus its event on direct investment from Chinese enterprises into US medical technology companies as well as licensing assets for China’s healthcare market. Driven by strong economic growth, an expanding middle class, and government support, China is forecasted to reach over $1 trillion annually in healthcare spending by 2020 and expected to be the second largest pharma market in the world by this year.
TPP Co-Founder and Managing Partner Asa Cox expressed, “We are very excited to have the opportunity to collaborate with one of the premier events in medical technology — and healthcare as a whole. The longstanding tradition of this annual event is a testament to the success and need for such a forum. We look forward to expanding on this year’s program with a broad range of new and exciting prospects in China.” US companies in a variety of spaces, ranging from medical device to telemedicine to more broadly digital health, will have the opportunity to meet with Chinese groups looking to invest, license, and distribute products and technologies.
A Chinese delegation of 30 institutional investors, public healthcare companies, and private healthcare companies will arrive in Palo Alto to partake in over 200 prearranged meetings. Initial diligence and an exchange of key materials will take place in the months prior to the event, ensuring that all meetings focus on deal terms and execution plans.
Tony Chu, Co-Founder and Managing Partner of TPP, explained, “We aim to facilitate in-depth, insightful, and ultimately successful discussions by providing comprehensive background information and materials prior to in-person meetings. The care taken to meticulously match groups based on a variety of characteristics and interests makes the partnering sessions most effective.”
In addition to the partnered meetings, an esteemed panel of Chinese executives, including representatives from Legend Capital, will speak during the Medical Device Conference on the following day. The panel will educate delegates on the immense opportunities for MedTech firms in China’s growing healthcare market.
About The Pharma Partners: The Pharma Partners (TPP) is a boutique advisory firm specializing in connecting innovative North American and European healthcare and life sciences companies with Chinese investment, manufacturing, and distribution groups.